Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV eradication revisited.

S Vella, L Palmisano

    Expert Opinion on Investigational Drugs
    |November 4, 2000
    PubMed
    Summary
    This summary is machine-generated.

    Current HIV eradication strategies have failed to eliminate the virus due to latent reservoirs. New combined immune-based and antiretroviral therapies aim to control HIV by preventing immune dysfunction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Imaging of primary malignant tumors in non-cirrhotic liver.

    Diagnostic and interventional imaging·2020
    Same author

    European survey on national training activities in clinical research.

    Trials·2019
    Same author

    The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons.

    The Journal of frailty & aging·2019
    Same author

    Cytomegalovirus (CMV) DNA load in breast milk of human immunodeficiency virus-positive women and infant CMV infection acquisition are not reduced with long-term antiretroviral therapy.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
    Same author

    A cross-sectional analysis of daytime versus nocturnal polysomnographic respiratory parameters in cystic fibrosis during early adolescence.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2016
    Same author

    Inorganic materials acting as heterogeneous photocatalysts and catalysts in the same reactions.

    Dalton transactions (Cambridge, England : 2003)·2016
    Same journal

    Investigational new drug TAP-1502 beginning clinical study for seborrheic dermatitis.

    Expert opinion on investigational drugs·2026
    Same journal

    Cannabinoid use in adults with sickle cell disease: therapeutic development and clinical insights.

    Expert opinion on investigational drugs·2026
    Same journal

    Odronextamab: a bispecific antibody for follicular lymphoma.

    Expert opinion on investigational drugs·2026
    Same journal

    Evaluating the investigational drug landscape for <i>ESR1</i>-mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer.

    Expert opinion on investigational drugs·2026
    Same journal

    Darigabat and subtype-selective GABA-A modulation: pharmacology, clinical development, and translational challenges.

    Expert opinion on investigational drugs·2026
    Same journal

    Safety, tolerability, and pharmacokinetics of HL-300, a novel topical pan-JAK inhibitor, in healthy Chinese adults: a first-in-human, randomized, double-blind, placebo-controlled phase I trial.

    Expert opinion on investigational drugs·2026
    See all related articles

    Area of Science:

    • Virology
    • Immunology
    • Infectious Diseases

    Background:

    • Current antiretroviral therapies suppress HIV replication but cannot eliminate the latent viral reservoir in CD4+ T lymphocytes.
    • Latently infected cells can reactivate, leading to viral rebound after treatment cessation.

    Discussion:

    • HIV eradication efforts have focused on eliminating the virus, but all attempts have been unsuccessful to date.
    • The persistent viral reservoir poses a significant challenge to achieving a complete cure for HIV infection.

    Key Insights:

    • Potent antiretroviral regimens effectively control viral load but do not clear the latent HIV reservoir.
    • Latent HIV reservoirs in CD4+ T cells are a major barrier to eradicating the infection.

    Outlook:

    Related Experiment Videos

    • Investigating combined immune-based and antiretroviral therapies to achieve viral control.
    • Future strategies aim to establish an equilibrium preventing immune dysfunction through an effective anti-HIV immune response.